Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin and pregnancy outcomes
IRCT2014042017365N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in preeclampsia, Preterm labor (PTL), intrauterine growth restriction (IUGR) and 1 more, sponsored by Urmia University of Medical Sciences. Primary endpoints: Preeclampsia incidence, Preterm labor incidence and 3 more. Started Aug 2013; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiaPreterm labor (PTL)intrauterine growth restriction (IUGR)stillbirth
Beyond the preview
Go deeper on IRCT2014042017365N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014042017365N1.